51596-06-6 Usage
Uses
Used in Pharmaceutical Industry:
2,5-dimethyl-1,2,4-triazolo[1,5-a]pyrimidin-7-ol is used as a sedative-hypnotic medication for the treatment of insomnia due to its ability to slow down brain activity and promote sleep. It is particularly beneficial for short-term insomnia treatment and is preferred by some individuals due to its lower risk of dependence and tolerance compared to other sleep medications.
Used in Sleep Aid Formulations:
2,5-dimethyl-1,2,4-triazolo[1,5-a]pyrimidin-7-ol is used as an active ingredient in sleep aid formulations to provide relief from insomnia. Its short-acting nature allows for effective sleep induction without the risk of prolonged sedation, making it suitable for individuals seeking temporary relief from sleep disturbances.
Used in Research and Development:
2,5-dimethyl-1,2,4-triazolo[1,5-a]pyrimidin-7-ol is utilized in research and development for the study of sleep disorders, sleep-wake cycles, and the development of new sleep medications. Its unique properties and lower risk of dependence make it an important compound for scientific investigation and potential therapeutic applications in the field of sleep medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 51596-06-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,5,9 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 51596-06:
(7*5)+(6*1)+(5*5)+(4*9)+(3*6)+(2*0)+(1*6)=126
126 % 10 = 6
So 51596-06-6 is a valid CAS Registry Number.
51596-06-6Relevant articles and documents
DIHYDROOROTATE DEHYDROGENASE INHIBITORS WITH SELECTIVE ANTI-MALARIAL ACTIVITY
-
Page/Page column 33, (2009/07/25)
Compounds according to Formula (I), Formula (II), Formula (III), Formula (V), Formula (VI), or to Formula (VII), and pharmaceutical compositions of compounds that conform to Formula (IV) or (Formula VIII): where R1 through R33 are prescribed, selectively inhibit P. falciparum dihydroorotate dehydrogenase. Accordingly, a method for preventing and treating malaria attaches to such compounds, as well as to pharmaceutically acceptable salts, solvates, stereoisomers, tautomers, and prodrugs thereof.